Watchlist Price Alert

Sino Biopharmaceutical Li... (SBHMY)

PNK: SBHMY · Real-Time Price · USD

9.75

-0.55 (-5.34%)

At close: May 07, 2025, 3:16 PM

Sino Biopharmaceutical Balance Sheet Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	9.57B	9.45B	8.65B	9.6B	10.62B	10.63B	6.24B	3.69B	3.5B
Short-Term Investments	5.03B	1.55B	8.27B	6.19B	5.81B	8.47B	6.79B	6.21B	5.07B
Long-Term Investments	26.34B	25.18B	16.96B	18.97B	5.1B	-6.45B	-5.28B	-3.94B	-3.39B
Other Long-Term Assets	1.04B	3.78B	9.5B	7.5B	9.45B	9.45B	6.78B	6.13B	5.27B
Receivables	4.97B	4.6B	4.64B	4.29B	2.91B	2.71B	2.92B	2.05B	2B
Inventory	2.37B	1.99B	2.33B	1.94B	1.88B	1.66B	1.21B	918.82M	894.64M
Other Current Assets	295.61M	2.52B	1.58B	1.25B	1.16B	630.76M	978.24M	710.33M	1.11B
Total Current Assets	24.69B	23.81B	25.93B	23.5B	22.79B	24.91B	18.54B	13.78B	12.73B
Property-Plant & Equipment	10.29B	9.91B	9.25B	8.52B	7.16B	6.98B	7.03B	4.27B	3.15B
Goodwill & Intangibles	3.06B	928.94M	1.91B	1.71B	2.25B	22.83B	22.25B	308.18M	281.43M
Total Long-Term Assets	40.72B	39.8B	38.13B	37.04B	24.42B	33.39B	31.24B	7.16B	5.67B
Total Assets	65.41B	63.6B	64.06B	60.54B	47.21B	58.3B	49.78B	20.94B	18.39B
Account Payables	1.5B	1.33B	1.88B	1.79B	1.95B	1.81B	1.83B	928.61M	826.73M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	192.92M
Short-Term Debt	7.68B	11.14B	9.8B	6.66B	1.55B	666.75M	2.91B	741.31M	1.37B
Other Current Liabilities	7.61B	3.35B	2.11B	1.68B	3.22B	2.06B	4.93B	1.25B	1.06B
Total Current Liabilities	19.56B	22.61B	20.15B	15.35B	10.94B	8.12B	9.67B	5.69B	5.65B
Long-Term Debt	2B	1.07B	3.93B	5.21B	12.36B	7.88B	507.07M	2.21B	1.68B
Other Long-Term Liabilities	997.36M	1.46B	1.71B	1.94B	1.22B	-2.12B	1.01B	n/a	-1.13M
Total Long-Term Liabilities	3.08B	2.83B	5.97B	7.47B	13.85B	9.89B	2.56B	2.64B	2.05B
Total Liabilities	22.63B	25.43B	26.12B	22.81B	24.79B	18.01B	12.23B	8.32B	7.7B
Total Debt	9.78B	12.58B	13.98B	12.12B	14.21B	8.62B	3.41B	2.95B	3.05B
Common Stock	414.38M	414.62M	414.9M	415.44M	415.89M	278.45M	278.85M	170.03M	165.92M
Retained Earnings	n/a	29.34B	23.07B	23.07B	13.6B	11.95B	16.81B	8.47B	5.34B
Comprehensive Income	n/a	n/a	-10.08B	-9.23B	-9.49B	-9.83B	-1.37B	-1.07B	-848.18M
Shareholders Equity	31.96B	30.47B	29.75B	30.29B	16.75B	31.11B	29.21B	9.21B	7.96B
Total Investments	31.36B	25.82B	25.23B	25.17B	10.91B	2.02B	1.07B	1.78B	1.41B